These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 17255310)
1. Osteoclasts: what do they do and how do they do it? Teitelbaum SL Am J Pathol; 2007 Feb; 170(2):427-35. PubMed ID: 17255310 [TBL] [Abstract][Full Text] [Related]
2. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426 [TBL] [Abstract][Full Text] [Related]
8. Integrin-associated molecules and signalling cross talking in osteoclast cytoskeleton regulation. Kong L; Wang B; Yang X; He B; Hao D; Yan L J Cell Mol Med; 2020 Mar; 24(6):3271-3281. PubMed ID: 32045092 [TBL] [Abstract][Full Text] [Related]
9. Canonical and non-canonical pathways of osteoclast formation. Knowles HJ; Athanasou NA Histol Histopathol; 2009 Mar; 24(3):337-46. PubMed ID: 19130404 [TBL] [Abstract][Full Text] [Related]
10. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K; Kudo A J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857 [TBL] [Abstract][Full Text] [Related]
11. alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Ross FP; Teitelbaum SL Immunol Rev; 2005 Dec; 208():88-105. PubMed ID: 16313343 [TBL] [Abstract][Full Text] [Related]
12. Role of IGF-I signaling in regulating osteoclastogenesis. Wang Y; Nishida S; Elalieh HZ; Long RK; Halloran BP; Bikle DD J Bone Miner Res; 2006 Sep; 21(9):1350-8. PubMed ID: 16939393 [TBL] [Abstract][Full Text] [Related]
13. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis. Cai X; Xing J; Long CL; Peng Q; Humphrey MB J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106 [TBL] [Abstract][Full Text] [Related]
14. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [TBL] [Abstract][Full Text] [Related]
15. Osteoclasts; culprits in inflammatory osteolysis. Teitelbaum SL Arthritis Res Ther; 2006; 8(1):201. PubMed ID: 16356195 [TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of osteoporosis development in patients with rheumatoid arthritis]. Matuszewska A; Szechiński J Postepy Hig Med Dosw (Online); 2014 Feb; 68():145-52. PubMed ID: 24491906 [TBL] [Abstract][Full Text] [Related]
17. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
18. [Inflammation and osteoclasts]. Yokota K Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):367-376. PubMed ID: 29238019 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of osteoclast function and pathways. Broadhead ML; Clark JC; Dass CR; Choong PF; Myers DE Expert Opin Ther Targets; 2011 Feb; 15(2):169-81. PubMed ID: 21204734 [TBL] [Abstract][Full Text] [Related]
20. Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis. Lin YY; Jean YH; Lee HP; Lin SC; Pan CY; Chen WF; Wu SF; Su JH; Tsui KH; Sheu JH; Sung PJ; Wen ZH Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28067799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]